Chapter 8

Novel Indications of Cardiac Resynchronization Therapy: Patients in Atrial Fibrillation, with Narrow QRS Complex and in Functional Class II

Ana Martin and Antonio Berruezo

Abstract

Randomized clinical trials have shown important clinical benefits from cardiac resynchronization therapy, in addition to those obtained with optimal medical treatment, in the advanced heart failure population. However, the criteria for inclusion in these trials are restrictive and only a small proportion of heart failure patients are candidates. The logical next step is to expand this therapy and its possible benefits to heart failure patients in less advanced stages of the disease, with narrow QRS and in atrial fibrillation. In this chapter we review the available findings on the use of this therapy in these subsets of patients.

Total Pages: 83-89 (7)

Purchase Chapter  Book Details

RELATED BOOKS

.Advancements in Cardiovascular Research and Therapeutics: Molecular and Nutraceutical Perspectives.
.Blood Oxidant Ties: The Evolving Concepts in Myocardial Injury and Cardiovascular Disease.
.Cardiac Care and COVID-19: Perspectives in Medical Practice.
.Nanomedicinal Approaches Towards Cardiovascular Disease.